This application is for the renewal of a Program Project that endeavors to improve understanding of the pathogenesis of glioblastoma multiforme (GBM). The Program comprises an interdisciplinary team of basic, translational and clinical scientists with a strong track record of working together and strengths in tumor biology, mouse genetics, genomics/informatics, and experimental pathology. This team will (i) dissect the role of GBM signature mutations in governing the tumor biological properties of the disease using a variety of model systems, (ii) identify, validate and characterize new GBM oncogenes and tumor suppressors, (iii) illuminate and validate the role of the EGFR-PI3K pathway in GBM using an array of genetic approaches, (iv) define and therapeutically manipulate key signaling molecules such as receptor and non-receptor tyrosine kinases in sophisticated genetically defined mouse and human models, and (v) understand how these newly discovered genetic elements modulate the response to EGFR inhibition. The Program consists of 3 Projects and 4 Cores that together encompass state-of-the-art genetic engineering, superb experimental pathology and biospecimen repositories, and extraordinary genomic and functional validation capabilities that will enable the team to provide a dynamic analysis of GBM biology and signaling in unprecedented detail. Project 1 will focus on the refinement of a unique high-grade glioma model, developed in the first period of the Program, by incorporating newly discovered glioma-relevant alleles emerging from genetic, functional genomic and proteomic studies throughout the Program. Project 2 exploits biochemical and cell biological analyses that are designed to understand activated EGFR signaling in GBM and how patients respond or progress when treated with EGFR kinase inhibitors. Project 3 is new to the renewal and combines strengths in oncogenomics and high throughput RNA interference with which they will identify a set of putative oncogenes that are not only amplified in GBM but also necessary for their proliferation and survival. Core A will provide Program investigators with sophisticated mouse modeling of mutations as well as an exceptional biorepository of astrocytes, neural stem cells, neurospheres and patient specimens. Core B will provide critical neuropathologic analyses of mouse and human tumor tissues. Core C will continue to provide critical genomics infrastructure and capabilities as well as essential computational and biostatistical support. Core D will provide the administrative oversight necessary to assure efficient and effective use of the Program resources. The long-term goal of these basic and preclinical efforts is to leverage institutional and other resources with the P01 in order to provide substantial synergies for pushing basic disease-related discovery to translation and in identifying and guiding opportunities for targeted drug discovery in this disease.
| Reardon, Colin; Murray, Kaitlin; Lomax, Alan E (2018) Neuroimmune Communication in Health and Disease. Physiol Rev 98:2287-2316 |
| Roncali, Emilie; Stockhoff, Mariele; Cherry, Simon R (2017) An integrated model of scintillator-reflector properties for advanced simulations of optical transport. Phys Med Biol 62:4811-4830 |
| Nanavaty, Vishal; Sandhu, Ranjodh; Jehi, Sanaa E et al. (2017) Trypanosoma brucei RAP1 maintains telomere and subtelomere integrity by suppressing TERRA and telomeric RNA:DNA hybrids. Nucleic Acids Res 45:5785-5796 |
| Liu, Rui; Yang, Guang; Zhou, Meng-Hua et al. (2016) Flotillin-1 downregulates K(+) current by directly coupling with Kv2.1 subunit. Protein Cell 7:455-60 |
| Schrager-Lavelle, Amanda; Herrera, Leslie A; Maloof, Julin N (2016) Tomato phyE Is Required for Shade Avoidance in the Absence of phyB1 and phyB2. Front Plant Sci 7:1275 |
| Hu, Baoli; Wang, Qianghu; Wang, Y Alan et al. (2016) Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell 167:1281-1295.e18 |
| Poornima, Gopalakrishna; Shah, Shanaya; Vignesh, Venkadasubramanian et al. (2016) Arginine methylation promotes translation repression activity of eIF4G-binding protein, Scd6. Nucleic Acids Res 44:9358-9368 |
| Frost, Bess; Bardai, Farah H; Feany, Mel B (2016) Lamin Dysfunction Mediates Neurodegeneration in Tauopathies. Curr Biol 26:129-36 |
| Leonard, Paul G; Satani, Nikunj; Maxwell, David et al. (2016) SF2312 is a natural phosphonate inhibitor of enolase. Nat Chem Biol 12:1053-1058 |
| Hiu, Takeshi; Farzampour, Zoya; Paz, Jeanne T et al. (2016) Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target. Brain 139:468-80 |
Showing the most recent 10 out of 146 publications
